DesRosier Thomas
Officer at MCRB; EVP, Chief Legal at CUBIST PHARMACEUTICALS INC; Sr VP, General Counsel at GENZYME CORP
- Sold, on record
- $1.1M
- Dollars the filings state
- Form 4 sales
- 18
- Latest Aug 17, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- MCRBSeres Therapeutics, Inc.Officer
- CUBIST PHARMACEUTICALS INCEVP, Chief Legal
- GENZYME CORPSr VP, General Counsel
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- MCRB28,664 shares
- GENZYME CORP12,697 shares
- CUBIST PHARMACEUTICALS INC768 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale MCRBRoutineNov 18, 2024 2024
Sold 878 shares at $0.54 ($474)
DesRosier Thomas, Chief Legal Officer and EVP
10b5-1 planSold 0.6% of holdings ($73k position)135,192 shares left0.2x usual sizeFiling
- 2 Form 4 sale MCRBRoutineFeb 18, 2025 +92 days
Sold 4,300 shares at $0.81 ($3k)
DesRosier Thomas, Chief Legal Officer and EVP
10b5-1 planSold 2.9% of holdings ($119k position)142,456 shares left1.8x usual sizeFiling
- 3 Form 4 sale MCRBRoutineMay 15, 2025 +86 days
Sold 79 shares at $7.28 ($575)
DesRosier Thomas, Chief Legal Officer and EVP
10b5-1 planSold 1.1% of holdings ($54k position)7,287 shares left0x usual sizeFiling
- 4 Form 4 sale MCRBRoutineAug 18, 2025 +95 days
Sold 76 shares at $16.65 ($1k)
DesRosier Thomas, Officer
10b5-1 planSold 1% of holdings ($125k position)7,455 shares left0x usual sizeFiling
- 5 Form 4 sale MCRBRoutineNov 15, 2025 +89 days
Sold 76 shares at $17.30 ($1k)
DesRosier Thomas, Officer
10b5-1 planSold 1% of holdings ($133k position)7,623 shares left0.1x usual sizeFiling
- 6 Form 4 sale MCRBRoutineFeb 15, 2026 +92 days
Sold 78 shares at $8.47 ($661)
DesRosier Thomas, Officer
10b5-1 planSold 1% of holdings ($67k position)7,789 shares left0.1x usual sizeFiling
- 7 Form 4 sale MCRBRoutineMay 18, 2026 +92 days
Sold 79 shares at $7.53 ($595)
DesRosier Thomas, Officer
10b5-1 planSold 1% of holdings ($60k position)7,954 shares left0.2x usual sizeFiling
- 8 Form 4 sale MCRBRoutineAug 17, 2026 +91 days
Sold 82 shares at $4.55 ($373)
DesRosier Thomas, Officer
10b5-1 planSold 1% of holdings ($37k position)8,117 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (18)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Aug 18, 2026 | MCRB | Officer | Form 4 sale | 82 | $373 | 1.0% | Routine | SEC |
| May 18, 2026 | May 19, 2026 | MCRB | Officer | Form 4 sale | 79 | $595 | 1.0% | Routine | SEC |
| Feb 15, 2026 | Feb 18, 2026 | MCRB | Officer | Form 4 sale | 78 | $661 | 1.0% | Routine | SEC |
| Nov 15, 2025 | Nov 18, 2025 | MCRB | Officer | Form 4 sale | 76 | $1k | 1.0% | Routine | SEC |
| Aug 18, 2025 | Aug 19, 2025 | MCRB | Officer | Form 4 sale | 76 | $1k | 1.0% | Routine | SEC |
| May 15, 2025 | May 19, 2025 | MCRB | Chief Legal Officer and EVP | Form 4 sale | 79 | $575 | 1.1% | Routine | SEC |
| Feb 18, 2025 | Feb 19, 2025 | MCRB | Chief Legal Officer and EVP | Form 4 sale | 4,300 | $3k | 2.9% | Routine | SEC |
| Nov 18, 2024 | Nov 19, 2024 | MCRB | Chief Legal Officer and EVP | Form 4 sale | 878 | $474 | 0.6% | Routine | SEC |
| Oct 28, 2024 | Oct 29, 2024 | MCRB | Chief Legal Officer and EVP | Form 4 sale | 4,259 | $3k | 3.1% | Routine | SEC |
| Aug 16, 2024 | Aug 19, 2024 | MCRB | Chief Legal Officer and EVP | Form 4 sale | 873 | $733 | 0.7% | Routine | SEC |
| May 15, 2024 | May 17, 2024 | MCRB | Chief Legal Officer and EVP | Form 4 sale | 843 | $792 | 0.7% | Routine | SEC |
| Feb 16, 2024 | Feb 16, 2024 | MCRB | Chief Legal Officer and EVP | Form 4 sale | 3,939 | $4k | 3.2% | Routine | SEC |
| Oct 30, 2023 | Oct 31, 2023 | MCRB | Chief Legal Officer and EVP | Form 4 sale | 4,156 | $6k | 3.5% | Routine | SEC |
| Jan 28, 2019 | Jan 29, 2019 | MCRB | Chief Legal Officer and EVP | Form 4 sale | 5,471 | $31k | 25.4% | Unusual | SEC |
| Jan 26, 2018 | Jan 30, 2018 | MCRB | Officer | Form 4 sale | 3,475 | $38k | 34.8% | Unusual | SEC |
| Apr 16, 2014 | Apr 16, 2014 | CUBIST PHARMACEUTICALS INC | EVP, Chief Legal | Form 4 sale | 768 | $49k | 32.3% | Unusual | SEC |
| May 25, 2010 | May 26, 2010 | GENZYME CORP | Sr VP, General Counsel | Form 4 sale | 1,972 | $90k | 27.1% | Unusual | SEC |
| Aug 7, 2008 | Aug 8, 2008 | GENZYME CORP | Sr VP General Counsel | Form 4 sale | 10,725 | $847k | 93.7% | Unusual | SEC |